Literature DB >> 10748864

The Epstein-Barr virus and its association with human cancers.

K R Baumforth1, L S Young, K J Flavell, C Constandinou, P G Murray.   

Abstract

The Epstein-Barr virus (EBV) has been linked to the development of a variety of human malignancies, including Burkitt's lymphoma, Hodgkin's disease, nasopharyngeal carcinoma, some T cell lymphomas, post-transplant lymphoproliferative disease, and more recently, certain cancers of the stomach and smooth muscle. This review summarizes these associations and in particular the role of the viral latent genes in the transformation process.

Entities:  

Mesh:

Year:  1999        PMID: 10748864      PMCID: PMC395716          DOI: 10.1136/mp.52.6.307

Source DB:  PubMed          Journal:  Mol Pathol        ISSN: 1366-8714


  175 in total

1.  DNA of Epstein-Barr virus. V. Direct repeats of the ends of Epstein-Barr virus DNA.

Authors:  D Given; D Yee; K Griem; E Kieff
Journal:  J Virol       Date:  1979-06       Impact factor: 5.103

2.  Epstein Barr virus nuclear antigen positive lymphoma after cyclosporin A treatment in patient with renal allograft.

Authors:  D H Crawford; J A Thomas; G Janossy; P Sweny; O N Fernando; J F Moorhead; J H Thompson
Journal:  Lancet       Date:  1980-06-21       Impact factor: 79.321

Review 3.  Epidemiology of Hodgkin's disease.

Authors:  N Gutensohn; P Cole
Journal:  Semin Oncol       Date:  1980-06       Impact factor: 4.929

4.  Long internal direct repeat in Epstein-Barr virus DNA.

Authors:  A Cheung; E Kieff
Journal:  J Virol       Date:  1982-10       Impact factor: 5.103

5.  Circulating Epstein-Barr virus-carrying B cells in acute malaria.

Authors:  K M Lam; N Syed; H Whittle; D H Crawford
Journal:  Lancet       Date:  1991-04-13       Impact factor: 79.321

6.  Long-term T-cell-mediated immunity to Epstein-Barr virus in man. III. Activation of cytotoxic T cells in virus-infected leukocyte cultures.

Authors:  D J Moss; A B Rickinson; J H Pope
Journal:  Int J Cancer       Date:  1979-05-15       Impact factor: 7.396

7.  Epstein-Barr virus in benign lymph node biopsies from individuals infected with the human immunodeficiency virus is associated with concurrent or subsequent development of non-Hodgkin's lymphoma.

Authors:  D Shibata; L M Weiss; B N Nathwani; R K Brynes; A M Levine
Journal:  Blood       Date:  1991-04-01       Impact factor: 22.113

8.  Patterns of chromosomal breakpoint locations in Burkitt's lymphoma: relevance to geography and Epstein-Barr virus association.

Authors:  B Shiramizu; F Barriga; J Neequaye; A Jafri; R Dalla-Favera; A Neri; M Guttierez; P Levine; I Magrath
Journal:  Blood       Date:  1991-04-01       Impact factor: 22.113

9.  Chromosome site for Epstein-Barr virus DNA in a Burkitt tumor cell line and in lymphocytes growth-transformed in vitro.

Authors:  A Henderson; S Ripley; M Heller; E Kieff
Journal:  Proc Natl Acad Sci U S A       Date:  1983-04       Impact factor: 11.205

10.  Two small RNAs encoded by Epstein-Barr virus and complexed with protein are precipitated by antibodies from patients with systemic lupus erythematosus.

Authors:  M R Lerner; N C Andrews; G Miller; J A Steitz
Journal:  Proc Natl Acad Sci U S A       Date:  1981-02       Impact factor: 11.205

View more
  37 in total

Review 1.  Molecular pathways in virus-induced cytokine production.

Authors:  T H Mogensen; S R Paludan
Journal:  Microbiol Mol Biol Rev       Date:  2001-03       Impact factor: 11.056

2.  Linkage between STAT regulation and Epstein-Barr virus gene expression in tumors.

Authors:  H Chen; J M Lee; Y Zong; M Borowitz; M H Ng; R F Ambinder; S D Hayward
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

3.  Themed issue: the biology and pathology of the Epstein-Barr virus.

Authors:  P G Murray; L S Young
Journal:  Mol Pathol       Date:  2000-10

Review 4.  Structural and functional distinctiveness of HLA-A2 allelic variants.

Authors:  Kenneth Yuanxiang Chen; Jingxian Liu; Ee Chee Ren
Journal:  Immunol Res       Date:  2012-09       Impact factor: 2.829

5.  Epstein-Barr virus in human malignancy: a special reference to Epstein-Barr virus associated gastric carcinoma.

Authors:  Mee Soo Chang; Woo Ho Kim
Journal:  Cancer Res Treat       Date:  2005-10-31       Impact factor: 4.679

6.  Resolution of Multifocal Epstein-Barr Virus-Related Smooth Muscle Tumor in a Patient with GATA2 Deficiency Following Hematopoietic Stem Cell Transplantation.

Authors:  Mark Parta; Jennifer Cuellar-Rodriguez; Alexandra F Freeman; Juan Gea-Banacloche; Steven M Holland; Dennis D Hickstein
Journal:  J Clin Immunol       Date:  2016-12-06       Impact factor: 8.317

7.  Epstein-Barr virus BGLF4 kinase downregulates NF-κB transactivation through phosphorylation of coactivator UXT.

Authors:  Ling-Shih Chang; Jiin-Tarng Wang; Shin-Lian Doong; Chung-Pei Lee; Chou-Wei Chang; Ching-Hwa Tsai; Sheng-Wen Yeh; Ching-Yueh Hsieh; Mei-Ru Chen
Journal:  J Virol       Date:  2012-08-29       Impact factor: 5.103

8.  Experimental infection of NOD/SCID mice reconstituted with human CD34+ cells with Epstein-Barr virus.

Authors:  Miguel Islas-Ohlmayer; Angela Padgett-Thomas; Rana Domiati-Saad; Michael W Melkus; Petra D Cravens; Maria del P Martin; George Netto; J Victor Garcia
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

9.  Involvement of Epstein-Barr virus (EBV)-encoded latent membrane protein (LMP)-1 in the potentiation of C epsilon mRNA expression in human tonsil-derived cells.

Authors:  Shigeto Ohta; Kazuhiko Hanashiro; Masanori Sunagawa; Tetsuya Tono; Mikio Suzuki; Tadayoshi Kosugi
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-11-07       Impact factor: 2.503

10.  Human monocytic cell lines transformed in vitro by Epstein-Barr virus display a type II latency and LMP-1-dependent proliferation.

Authors:  Eric Masy; Eric Adriaenssens; Claire Montpellier; Pascale Crépieux; Alexandra Mougel; Brigitte Quatannens; Gautier Goormachtigh; Nathalie Faumont; Fabienne Meggetto; Claude Auriault; Hervé Groux; Jean Coll
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.